Epstein Secrets

bigger. The IP exclusivity could potentially be enjoyed by Veru up to 2036 from the Tamsulosin franchise that it licensed from Ariana Therapeutics. Ariana (now Camargo) would receive $10M over three years after the drug has been in market for one year. Tamsulosin XR and DRS would be addressing a well-

41-6. Public Companies Mentioned in this Report: Astellas Pharma (ALPMY — NR - $15.00) Eli Lilly (LLY — NR - $78.60) Merck & Co (MRK -NR-$54.54) Pfizer Inc. (PFE -NR-$36.13) Johnson & Johnson. (JNJ -NR-$130.41) 24 EFTA00810599 BROOKLINE CAPITAL MARKETS A Division of CIM Securities Veru, Inc. (VEIV

EFTA02686129 John Hourican Lloyd Walter Howell W. Lee Howell Rumen Hranov Hsu Ta-Lin George Hu Ken Hu Hu Shuli Philippe Huber Ian Hudson Manna Huffington Peter I-Killen Goren Hultin Glenn H. Hutchins William N. Hutton David lakobachvili Herminia lbarra Riswinandi Idris Enrique V. Iglesias Davi

d Chief Executive Officer Desjardins Group The Boston Consulting Group Lloyd's Yale University DareDevil Strategies Amobee Publicis Groupe SA Pfizer Inc. Accel Partners Center for China in the World Economy (CCWE) The George Institute for Global Health Balderton Capital thesystemis Bloomberg Ne

Horswill John Hourican Lloyd Walter Howell Jr W. Lee Howell Rumen Hranov M. Sc. Hsu Ta-Lin George Hu Ken Hu Hu Shuli Philippe Huber lan Hudson Arianna Huffington Peter van Hillen Géran Hultin Glenn H. Hutchins William N. Hutton David lakobachvili Herminia Ibarra Riswinandi Idris Chief Economic Corresponde

mpa Harvard Business School Desjardins Group The Boston Consulting Group Lloyd's Yale University DareDevil Strategies Amobee Publicis Groupe SA Pfizer Inc. Center for China in the World Economy (CCWE) Accel Partners The George Institute for Global Health Balderton Capital thesystemis Bloomberg New En